课题基金 / 基金详情

PROJECT 4: VULNERABILITY TO WHITE MATTER PROGRESSION IN SCHIZOPHRENIA

PROJECT 4: VULNERABILITY TO WHITE MATTER PROGRESSION IN SCHIZOPHRENIA
项目 4:精神分裂症患者白质进展的脆弱性
批准号:
8136029
负责人:
Martha E. Shenton
金额:
$41.59万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2012-08-31
关键词:
Acute Erythroblastic LeukemiaAgeAmygdaloid structureAnisotropyAnteriorAreaAstrocytesAutopsyBiological MarkersBiological Neural NetworksBrainBrain regionCaliberCandidate Disease GeneCell NucleusCellsChronicChronic SchizophreniaClinicalCognitiveCommunicationComplexCorpus CallosumCyclic NucleotidesDataDatabasesDevelopmentDiagnosisDiffusionDiffusion Magnetic Resonance ImagingDiseaseDorsalEtiologyFiberFunctional disorderGenderGene ExpressionGenesGeneticGenetic VariationGlycoproteinsHippocampus (Brain)Homologous GeneHospitalizationHumanImageImmigrationIndividualInferiorInternal CapsuleInvestigationLeadLeftLesionLimb structureLinkLiteratureLobuleMagnetic Resonance ImagingMatched GroupMeasuresMedialMemoryMessenger RNAMetabolismMyelinMyelin Associated GlycoproteinN-MethylaspartateNRG1 geneNeurogliaNeuronsOligodendrogliaOnset of illnessParietalPathologic ProcessesPathologyPatientsPlayProteinsRecording of previous eventsRegulationReverse Transcriptase Polymerase Chain ReactionRiskRoleSchizophreniaSignal TransductionSingle Nucleotide PolymorphismSourceStagingStructure of supramarginal gyrusSuggestionSuperior temporal gyrusSusceptibility GeneSymptomsSynapsesTemporal LobeTestingThalamic structureThickTimeTranscriptVariantViral Oncogeneanterior commissurebasecohortdensityfirst episode schizophreniafollow-upfrontal lobegenetic associationgray matterinsightinterestlaser capture microdissectionmetabotropic glutamate receptors type 3neuroimagingneuropathologyneurotransmissionoligodendrocyte-myelin glycoproteinphosphoric diester hydrolaseprogression markersynaptic functionwhite matter

项目摘要

项目成果

Martha E. Shenton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent MRI studies demonstrate progressive changes in gray matter in temporal and frontal cortices following onset of schizophrenia. Far less, however, is known about white matter abnormalities, particularly fronto-temporal connections, long thought to be abnormal in schizophrenia. Additionally, post-mortem studies indicate that astrocytes and oligodendrocytes may be abnormal. Since glial cells play an important role in neuronal migration and in synaptic function, their dysfunction could lead to reduced neuronal size, reduced levels of synaptic proteins, as well as to abnormalities in neurotransmission and functional dysconnectivity. Of further note, recent genetic studies point to oligodendrocyte and myelin related (OMR) abnormalities. Taken together, these findings indicate that an investigation of white matter may lead to a further understanding of the neuropathology of schizophrenia. The main aim of this project is to investigate evidence for vulnerability to progression of white matter abnormalities in schizophrenia, at various stages of the illness (i.e., before, at first onset, long after illness onset), in order to delineate possible putative markers. Subjects will be: (1) 75 prodrome at risk subjects at study entry and at 1-year follow-up, and for those who convert to a first episode of schizophrenia, also at time of entry into the first episode study; (2) 80 first episode schizophrenia, defined by first hospitalization, at study entry.and followed at 6-mths and 18-mths; (3) 42 patients diagnosed with chronic schizophrenia. Normal controls will be group matched for age, gender, etc., to each cohort. We will use Diffusion Tensor Imaging to evaluate fronto-temporal white matter fiber connections (uncinate fasciculus, cingulate bundle, arcuate fasciculus, and fornix), corpus callosum, anterior commissure, and anterior limb of internal capsule, where we predict decreased anisotropy in chronic schizophrenics>first episode with changes at 18 months>first episode changes at 6 months>prodromes who convert>prodromes who do not convert. We also predict associations with OMR genes, where we will test for association between gene sequence variants (single nucleotide polymorphisms-SNPs) for six OMR genes (NRG1, ErbBS, MAG, CNP, MOG, GRM3). (See also Postmortem Core for isolation of mRNA from 4 OMR genes-ErbB3, MAG, CNP, MOG). This proposal will provide new discoveries relevant to white matter progression in schizophrenia, which will likely lead to new treatment and preventative strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of MR Biomarkers of Brain Injury in Acute and Chronic mTBI
  • 批准号:
    9017823
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    Martha E. Shenton
  • 依托单位:
Development of MR Biomarkers of Brain Injury in Acute and Chronic mTBI
  • 批准号:
    9392487
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    Martha E. Shenton
  • 依托单位:
Development of MR Biomarkers of Brain Injury in Acute and Chronic mTBI
  • 批准号:
    8675403
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    Martha E. Shenton
  • 依托单位:
CORE 3: IMAGING
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: